logo
AI Icon𝛼SK or Search
ENTITY

Duality Biotherapeutics (9606 HK)

71
Analysis
Health Care • China
Duality Biotherapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of next-generation antibody-drug conjugates (ADCs) to treat cancer and autoimmune diseases. The company develops a pipeline of ADC candidates, including DB-1303/BNT323 (HER2 ADC), DB-1311/BNT324 (B7-H3 ADC), DB-1310 (HER3 ADC), and DB-1305/BNT325 (TROP2 ADC), for various cancers. Duality Biotherapeutics is headquartered in Shanghai, China, and was founded in 2019.
more
Company Event • 22 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 28 Aug 2026 18:30 • Upcoming
Add To Calendar

H1 2026

Company Event • 25 Mar 2026 17:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 23 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 26 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x